Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Hepatitis C: early-phase trial registry
A small indexed set (17 trials) with no open enrollment listed right now.
Corpus placement: #1,004 of 28,707 conditions by registered trial count.
17 US clinical trials · none currently recruiting · #1,004 of 28,707 conditions by registered trial count
Chronic Hepatitis C: 17 US clinical trials tracked, none currently recruiting.
Chronic Hepatitis C is the subject of 17 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 4 are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most active sponsor is Bristol-Myers Squibb, running 4 of these trials.
Enrollment posture brief
Registry condition chronic-hepatitis-c
OPEN 0 | RECR 0% | LATE 4 | EARLY 11 | RANK #1004 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Chronic Hepatitis C has no open enrollment in this registry pull (17 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Hepatitis C on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Hepatitis C is recruiting below its size-band peers.
0 of 17 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Chronic Hepatitis C research.
Bristol-Myers Squibb accounts for 4 of 17 trials (23.5%). 13 distinct sponsors appear on at least one study for this condition label.
-
Most Chronic Hepatitis C trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 17 trials that report a genuine target (sentinel values excluded). 12 of those (70.6%) plan for fewer than 100 participants.
-
Chronic Hepatitis C research is mostly interventional.
15 interventional and 2 observational studies make up this index (88.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Indexed trials (enrollment closed)
17 total, page 1 of 1
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00006164
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
Human Genome Sciences
NCT00411385
Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
Gilead Sciences
NCT01625338
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Bristol-Myers Squibb
NCT01455090
Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment
National Center for Complementary and Integrative Health (NCCIH)
NCT00680342
A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects
Bristol-Myers Squibb
NCT00546715
A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment
Debiopharm International
NCT00537407
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
Bristol-Myers Squibb
NCT00983957
Pioglitazone in Hepatitis C
University of Michigan
NCT00189163
Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin
Bader, Ted, M.D.
NCT00487318
New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT01888900
Q-Trial in Patients With Hepatitis C
University of California, Los Angeles
NCT01438320
A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection
Trek Therapeutics, PBC
NCT02716428
A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects
Bristol-Myers Squibb
NCT00664625
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Duke University
NCT02006823
Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV
SciClone Pharmaceuticals
NCT01310205
Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance
Pfizer
NCT01210404
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 6 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Hepatitis C records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Hepatitis C trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Hepatitis C page
17 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Chronic Hepatitis C trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Bristol-Myers Squibb sponsors the most Chronic Hepatitis C trials on record, review their full trial history before evaluating a specific study. See Bristol-Myers Squibb's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Hepatitis C condition card totals 17 registered trials; most-linked intervention Ribavirin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.